Loading...
XHKG
0401
Market cap4mUSD
Apr 08, Last price  
0.06HKD
1D
8.93%
1Q
15.09%
Jan 2017
-98.43%
IPO
-98.33%
Name

Wanjia Group Holdings Ltd

Chart & Performance

D1W1MN
P/E
—
P/S
0.19
EPS
—
Div Yield, %
—
Shrs. gr., 5y
31.35%
Rev. gr., 5y
13.42%
Revenues
181m
+4.25%
1,885,369,0002,096,455,0001,567,687,0001,321,763,000985,909,000616,409,00096,480,00096,977,000114,086,000154,823,000173,702,000181,092,000
Net income
-40m
L
41,763,00048,920,000-772,949,000-13,802,000-25,792,000-55,586,000-66,592,000-20,744,000-4,536,000-50,999,0001,820,000-39,977,000
CFO
9m
-0.88%
-46,885,0008,942,000577,000183,586,00010,455,00043,303,000-46,533,00021,903,0007,611,0002,120,0009,385,0009,302,000

Profile

Wanjia Group Holdings Limited, an investment holding company, engages in pharmaceutical wholesale and distribution business in the People's Republic of China and Hong Kong. It also offers hemodialysis treatment and consultancy services. The company sells its products to hospitals and healthcare institutions; and companies operating pharmaceutical retail chain stores, independent pharmacies, outpatient departments of community hospitals, healthcare service stations, and clinics in Fujian province. Wanjia Group Holdings Limited was founded in 2004 and is headquartered in Kowloon, Hong Kong.
URL
https://www.wanjia-gp.com/
IPO date
Oct 11, 2013
Employees
202
Domiciled in
HK
Incorporated in
KY

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
181,092
4.25%
173,702
12.19%
Cost of revenue
191,899
176,148
Unusual Expense (Income)
NOPBT
(10,807)
(2,446)
NOPBT Margin
Operating Taxes
(854)
517
Tax Rate
NOPAT
(9,953)
(2,963)
Net income
(39,977)
-2,296.54%
1,820
-103.57%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
4,055
10,019
Long-term debt
25,454
32,863
Deferred revenue
Other long-term liabilities
Net debt
11,281
33,006
Cash flow
Cash from operating activities
9,302
9,385
CAPEX
(3,409)
(3,914)
Cash from investing activities
674
(3,844)
Cash from financing activities
(1,042)
(802)
FCF
(1,851)
59,494
Balance
Cash
18,228
9,876
Long term investments
Excess cash
9,173
1,191
Stockholders' equity
(7,429)
59,928
Invested Capital
98,224
142,882
ROIC
ROCE
EV
Common stock shares outstanding
560,222
560,222
Price
0.18
 
Market cap
100,840
 
EV
135,876
EBITDA
(394)
9,477
EV/EBITDA
14.34
Interest
1,711
2,018
Interest/NOPBT